A new report by Stratview Research with the title Global Molecular Diagnostics Market by manufacturers, regions, type, and application, forecast to 2027 comprises a detailed study of market size, share, and dynamics. The report is an illustrative sample demonstrating global Molecular Diagnostics Market trends, product category type, and market status. The report will help you understand the various applications of the usage and features of the product. It also covers the present and past market scenarios, market development patterns, and is likely to proceed with a continuing development over the forecast period.
Market Overview:
The molecular diagnostics market was estimated at USD 23.6 billion in 2021 and is likely to grow at a CAGR of 4.6% during 2022-2027 to reach USD 30.9 billion by 2027.
Our analysts keep a close eye on recent developments and follow the latest company news related to different players operating in the global Molecular Diagnostics Market. This helps us to deeply analyze companies as well as the competitive landscape.
Market Segmentation - By Product, Technique, Application, End-User Regions:
The market structure is demonstrated by analysing segments such as product type, application, key regions, and key companies.
By Product Type
Based on the product type, the market is segmented as reagents kits, instruments, and others. The reagents kits segment is expected to hold the major share of the market during the forecast period. The high use of reagents in molecular diagnostic testing, increasing demand for over-the-counter diagnostic tests, and growing adoption of these tests in non-medical facilities such as home self-testing are driving the segment's growth.
By Application Type
Based on the application type, the market is segmented as infectious diseases, blood screening, oncology, genetic tests, and others. Infectious diseases are estimated to account for the major share of the market during the forecast period on account of the increasing number of infectious diseases such as SARS-CoV-2, new multidrug-resistant TB, H1N1, and HIV strains.
By Region
In terms of regions, North America is expected to be the leading region in the market during the forecast period, owing to a growing geriatric population, increasing demand for point-of-care diagnostics, and outbreaks of bacterial and viral diseases. Furthermore, technological advancements, the presence of well-established diagnostic systems, and development in the healthcare sector are expected to drive market growth during the forecast period. Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.
The top leading players operating in the market:
The key players of the global Molecular Diagnostics Market are –
- Agilent Technologies, Inc.
- BioMerieux SA
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Illumina, Inc.
- Novartis AG
- QIAGEN N.V.
- Siemens Healthineers AG
- TBG Diagnostics Limited
- Thermo Fisher Scientific Inc.
Customization of the Report:
At Stratview Research, we understand that every company has a different requirement. And hence, we offer customization of the reports to meet the clients’ requirements. Please connect with our sales team ([email protected]), who will ensure that you get a report that suits your needs. You can also touch a chord with our executives at +1-313-307-4176 to share your research requirements.
About Us –
Stratview Research is a leading global Market Research firm providing expert research solutions, trusted by clients worldwide. This firm possesses a global presence to enable current market information using the most up-to-date methodology, best-in-class research techniques, and cost-effective approaches. It also surveys clients in several countries to provide you with the most comprehensive illustration of global trends and behaviours.
